Literature DB >> 9284759

Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas.

C Tanaka1, K Yoshimoto, P Yang, T Kimura, S Yamada, M Moritani, T Sano, M Itakura.   

Abstract

To study the etiologic roles of genes on chromosome 12 for the pituitary tumorigenesis of adenomas, mutations of the p27Kip1 gene and allelic ratios of 18 microsatellite markers on the entire chromosome 12 were studied in 33 pituitary adenomas. The p27Kip1 gene on chromosome 12p12-p13 encoding an inhibitor of complexes between cyclins and cyclin-dependent kinases is supposed to function as the tumor suppressor gene. Among 31 sporadic and 2 familial pituitary adenomas, PCR-single strand conformation polymorphism analysis detected three polymorphic changes but no tumor-specific mutations of the p27Kip1 gene. Genotyping of 18 microsatellite markers on the entire chromosome 12 detected the uniformly decreased allelic ratios ranging from 54-66% in 8 of 33 pituitary adenomas (24%), although no loss of heterozygosity was detected. Fluorescence in situ hybridization confirmed trisomy 12 in all 5 available samples out of these 8 samples. Based on these, we conclude that not mutations of the p27Kip1 gene, but trisomy 12 may be etiologically important in a subgroup of pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284759     DOI: 10.1210/jcem.82.9.4202

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  The p27/Kip1 locus shows no loss of heterozygosity in human pituitary adenomas.

Authors:  J C Wilson; J J Zhu; P M Black
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  The Art and Applications of Fluorescence In Situ Hybridization in Endocrine Pathology.

Authors:  George Kontogeorgos
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

3.  Examination of the relationship between chromosome abnormality in pituitary adenomas and tumor invasiveness by normal karyotype analysis and interphase fluorescence staining.

Authors:  Heng Gao; Qiping Wang; Sirong Wu; Guozhen Hui
Journal:  Med Oncol       Date:  2012-07-07       Impact factor: 3.064

Review 4.  The non-canonical functions of p27(Kip1) in normal and tumor biology.

Authors:  Savitha S Sharma; W Jackson Pledger
Journal:  Cell Cycle       Date:  2016-04-15       Impact factor: 4.534

5.  Cyclins D1 and D3 and topoisomerase II alpha in inactive pituitary adenomas.

Authors:  W Saeger; S Schreiber; D K Lüdecke
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

6.  Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.

Authors:  K Komatsubara; S Tahara; K Umeoka; N Sanno; A Teramoto; R Y Osamura
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 7.  Molecular pathogenesis of acromegaly.

Authors:  M R Drange; S Melmed
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

Review 8.  p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.

Authors:  R V Lloyd; L A Erickson; L Jin; E Kulig; X Qian; J C Cheville; B W Scheithauer
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

9.  Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis.

Authors:  Audrey Roussel-Gervais; Steve Bilodeau; Sophie Vallette; France Berthelet; André Lacroix; Dominique Figarella-Branger; Thierry Brue; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2010-07-21

10.  Effect of Dopamine Agonists on Lactotroph Adenomas of the Human Pituitary.

Authors:  Lucia Stefaneanu; Kalman Kovacs; Bernd W. Scheithauer; George Kontogeorgos; Darren L. Riehle; Thomas J. Sebo; David Murray; Sergio Vidal; Ami Tran; Michael Buchfelder; Rudolf Fahlbusch
Journal:  Endocr Pathol       Date:  2000       Impact factor: 4.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.